Osivelotor clinical trials

A Phase 2/3 Study in Adult and Adolescent Participants With SCD

This study is looking at a new medicine called osivelotor for people with sickle cell disease. It aims to see if it's safe, how well it works, and what dose is best. Both adults and teenagers can take part.